Role of Survivin Gene Promoter Polymorphism (−31G>C) in Susceptibility and Survival of Esophageal Cancer in Northern India
- 19 October 2010
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 18 (3) , 880-887
Abstract
Survivin is an upregulated inhibitor of apoptosis protein in esophageal cancer (EC), and a promoter region polymorphism (−31G>C) in the survivin gene has been reported as a modulator of gene expression. We aim to explore the role of survivin −31G>C polymorphism in susceptibility and survival of EC patients in northern Indian population. A case–control study was performed in 500 subjects (250 EC patients and 250 controls), and genotyping was done by polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) method. Survivin CC genotype was found to be significantly associated with EC susceptibility [odds ratio (OR) = 2.29; 95% confidence interval (CI) = 1.27–4.14; P = 0.006], particularly in males (OR = 4.91; 95% CI = 2.19–11.02; P = 0.0001) having squamous cell carcinoma (SCC) histopathology (OR = 2.4; 95% CI = 1.36–4.21; P = 0.002) at middle third esophagus location (OR = 2.60; 95% CI = 1.40–4.82; P = 0.002). Patients carrying CC genotype were found to have higher susceptibility to lymph node metastasis (OR = 2.82; 95% CI = 1.46–5.48; P = 0.002). However, on survival analysis, no prognostic role of survivin −31G>C polymorphism was detected. In case-only analysis, no gene–environment interaction was observed. Survivin promoter region polymorphism (−31G>C) is associated with susceptibility and clinical characteristics but not prognosis of esophageal cancer in northern Indian population.Keywords
This publication has 37 references indexed in Scilit:
- Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significanceClinical & Experimental Metastasis, 2009
- Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese PopulationDigestive Diseases and Sciences, 2008
- Esophageal cancer: epidemiology, pathogenesis and preventionNature Clinical Practice Gastroenterology & Hepatology, 2008
- Role of GSTM3 Polymorphism in the Risk of Developing Esophageal CancerCancer Epidemiology, Biomarkers & Prevention, 2007
- Survivin promoter polymorphism and cervical carcinogenesisJournal of Clinical Pathology, 2006
- Polo-like kinase and survivin are esophageal tumor-specific promotersBiochemical and Biophysical Research Communications, 2006
- A Mutation Found in the Promoter Region of the Human Survivin Gene Is Correlated to Overexpression of Survivin in Cancer CellsDNA and Cell Biology, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999